Illumina Inc. (ILMN)
Last updated: 2026-10-20 12:57:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Illumina Inc. (ILMN) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $260.55, with a market capitalization of $39.64B and a P/E ratio of 48.07. Over the past 52 weeks, its price has ranged from $94.00 to $309.35. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$39.64B | |
$262.70 | |
$555.77 | |
$1.94 | |
$262.66 | |
270.00 | |
2.79M | |
48.07 | |
$309.35 | |
$94.00 | |
-- | |
2001-12-27 |
Illumina Inc. (ILMN) Pre-Market Stock Price
Illumina Inc. (ILMN) is trading at $260.55 in pre-market trading as of 2026-10-20 12:49:00, down 0.81% ($2.12) from the previous close of $262.66
Pre-market trading shows how investors are pricing ILMN before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Illumina Inc. (ILMN) 7-Day Stock Price Change
Over the past seven days, Illumina Inc. (ILMN) moved from $278.17 to $260.55, representing a decline of 6.34% ($17.63).
The stock traded between $257.14 and $278.59 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.13 million shares, down versus the previous seven-day period, indicating lower trading activity.
ILMN 52-Week Price Position
Position in Range: 77.3%
ILMN is currently trading at $260.55, placing it 77.3% of the way from its 52-week low of $94.00 to its 52-week high of $309.35. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Illumina Inc. (ILMN)?
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Illumina Inc. Information
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 8650 |
| CEO | Jacob Thaysen |
| Founded | 1998 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Illumina Inc. (ILMN) Stock on MEXC
Eligible investors can buy real shares of Illumina Inc. (ILMN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Illumina Inc. (ILMN) stock price today?
2.Is ILMN stock going up or down today?
3.What is ILMN pre-market price?
4.What is ILMN after-hours price?
5.Is ILMN stock trading now?
6.Where does ILMN sit relative to its 52-week high and low?
7.What sector is Illumina Inc. in?
8.What is Illumina Inc.'s market capitalization and where is it listed?
9.How is ILMN valued in terms of P/E ratio and EPS?
10.Does Illumina Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ILMN Stock Calculator
Estimate the value between ILMN shares and USD.
ILMN Shares to USD
1.00 ILMN shares = 260.545 USD
Calculations are estimates based on the latest available price and are for reference only.


